Secondary use of data study characterizing Kesimpta (ofatumumab) onboarding and utilization in RMS patients using MSGo, with a non-interventional primary use of data sub-study comparing Patient Reported Outcomes relative to Clinical Outcomes (EAFToS) (NCT05090033)
COMB157GAU01
This trial is No longer recruiting
Registration number NCT05090033
Program & service
This trial is being run with the Brain service, and as part of the MSNI program.
Trial phase
Phase 1
Trial participation type
This trial is for clinical research of something other than a drug or device.
Principal investigator
Associate Professor Anneke Van Der Walt
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR